155 Episodio

  1. Should Wellness Products Come with a Warning?

    Pubblicato: 11/09/2025

  2. 3 Most Common Premarket (Postmarket?) Review Issues FDA Sees

    Pubblicato: 25/06/2025

  3. Why Are One-Third of MAUDE Reports a Problem?

    Pubblicato: 10/06/2025

  4. FDA Guidance on Off-Label Communication, Part 1

    Pubblicato: 30/05/2025

  5. FDA Guidance on Off-Label Communication, Part 2

    Pubblicato: 30/05/2025

  6. Development Considerations for Over-the-Counter Medtech, Part 1

    Pubblicato: 23/01/2025

  7. Development Considerations for OTC Medtech, Part 2

    Pubblicato: 23/01/2025

  8. Device Descriptions in Regulatory Submissions

    Pubblicato: 07/01/2025

  9. Regulatory Ramifications Due to the Presidential Election

    Pubblicato: 26/11/2024

  10. Regulatory Considerations with an Assisted Suicide Machine

    Pubblicato: 20/11/2024

  11. Predetermined Change Control Plans, Part 2

    Pubblicato: 24/09/2024

  12. Predetermined Change Control Plans, Part 1

    Pubblicato: 24/09/2024

  13. What is a CAPA and How Do You Best Use It?

    Pubblicato: 03/09/2024

  14. You Got a 483 from the FDA. Now what?

    Pubblicato: 22/08/2024

  15. Revisiting Real-World Evidence

    Pubblicato: 18/06/2024

  16. The Most Dangerous Devices to Hit the Market

    Pubblicato: 11/06/2024

  17. Headline-Generating Medical Device Safety Concerns

    Pubblicato: 02/05/2024

  18. Analyzing ECRI’s 2024 Top 10 Health Technology Hazards

    Pubblicato: 19/03/2024

  19. Examining Institutional Review Boards

    Pubblicato: 06/03/2024

  20. Reimbursing Breakthrough Designation Products

    Pubblicato: 02/01/2024

1 / 8

A podcast focused on the medical device technology industry, from design and development to outsourcing services and relationships to finished medtech products.

Visit the podcast's native language site